azn stock price: AstraZeneca share overview

AZN (AstraZeneca PLC) stock price

This guide explains how to find and interpret the azn stock price, where AZN trades, the data fields and metrics investors use, and the main factors that move AstraZeneca Plc shares. Read on to learn how to check the azn stock price in real time or delayed form, compare listings, understand dividends and corporate actions, and follow relevant news — plus practical steps to view AZN quotations via Bitget.

Company overview

AstraZeneca PLC is a global biopharmaceutical company focused on discovering, developing and commercializing prescription medicines. Key therapeutic areas include oncology, cardiovascular/renal/metabolism (CVRM), respiratory and immunology, and rare diseases. Corporate performance in research and development (clinical trial results and regulatory approvals), product sales, and cost control are central to how the azn stock price is valued by markets.

AstraZeneca’s commercial success for major products, progress in late-stage trials, and partnerships or licensing agreements all feed into investor expectations and therefore into the azn stock price. Institutional ownership, analyst coverage, and macroeconomic conditions (currency, interest rates) also shape AZN’s market valuation.

Ticker symbols and listings

• Primary ADR/ADS ticker (U.S.): AZN — AstraZeneca’s American Depositary Receipt may be quoted on major U.S. exchanges. The azn stock price is commonly referenced in U.S. dollar terms for ADR listings.
• Primary UK listing: AstraZeneca PLC ordinary shares trade on the LSE under a local ticker (commonly shown on London-based market pages). The azn stock price on U.K. venues is denominated in GBP for ordinary shares.
• Ordinary shares vs ADR/ADS: Ordinary shares (U.K.) represent direct holdings on the home market; ADR/ADS units represent depositary receipts that give U.S. investors exposure to the company in USD. Differences in liquidity, settlement and currency convertibility can lead to slight price differentials between listings, which are reflected in respective azn stock price quotes.
• Typical trading hours: U.S. exchange hours and U.K. hours differ; pre-market and after-hours sessions in the U.S. produce extended azn stock price movements outside core session times.

How the AZN stock price is quoted

Understanding how the azn stock price appears on different platforms is essential:

• Real-time quotes vs delayed quotes: Free market pages may show delayed azn stock price data (commonly delayed by 15–20 minutes). Professional feeds or broker platforms often provide real-time pricing.
• Bid / Ask vs Last trade: The azn stock price shown as “last” reflects the most recent trade. Bid and ask show the best available buying and selling prices and help reveal spread and liquidity.
• Pre-market / After-hours: Extended sessions can move the azn stock price outside regular hours; these quotes are often prefixed to indicate extended-hours data.
• Quote sources: Common quote sources include major financial data providers and exchange feeds. When checking the azn stock price, confirm whether the feed is realtime or delayed and whether it covers the ADR or ordinary shares.

Key market data and metrics

Investors typically review several metrics alongside the azn stock price:

• Current price and percent change (azn stock price % change)
• Day range (low/high) and 52-week range
• Market capitalization — total equity value at the current azn stock price
• Volume and average volume — measuring liquidity and trading interest in AZN
• Price-to-earnings (P/E) ratio and earnings per share (EPS)
• Dividend yield, trailing and forward yields, and ex-dividend date
• Beta (volatility relative to market), shares outstanding

Each metric adds context to the azn stock price. For example, market cap places AZN within large-cap peer groups, while volume and bid/ask spread inform about trading liquidity.

Historical price performance

Historical azn stock price performance is tracked over multiple horizons: intraday, year-to-date (YTD), 1-year, 3-year, 5-year, and since IPO or listing. Adjusted historical series account for corporate actions (stock splits, ADS conversions, dividends) so that total return comparisons reflect reinvested dividends and splits.

How to interpret historical AZN price charts:

• Short-term moves (intraday to YTD) often reflect news, earnings and clinical updates.
• Multi-year trends capture larger shifts tied to product launches, patent cliffs, and strategic M&A.
• Use adjusted price charts when comparing returns across different periods to reflect dividend payouts and corporate actions.

Data providers and brokerage platforms typically allow users to pull historical azn stock price data and export tables for analysis.

Dividends and corporate actions

AstraZeneca has an established dividend policy (subject to board approval). For ADR/ADS holders, dividend payments are typically converted into USD and shown on quotes as trailing/forward dividend yield and indicated dividend amount.

Common dividend-related fields shown with the azn stock price include:

• Ex-dividend date — the first day the stock trades without the next dividend entitlement
• Record date and payment date
• Dividend amount and yield (trailing 12 months and forward estimates)

Other corporate actions affecting the azn stock price include stock splits, ADS/ADR conversion mechanics, spin-offs, and M&A announcements. Corporate actions can change shares outstanding, which in turn affects per-share metrics and market capitalization.

Drivers of AZN share price

The azn stock price responds to both company-specific fundamentals and broader market factors:

Fundamental drivers

• Clinical trial outcomes and regulatory approvals or rejections — often lead to immediate azn stock price reaction.
• Product launches, sales performance and commercial execution — stronger-than-expected sales can lift the azn stock price.
• Patent expirations, generic competition or biosimilar entry — these can pressure revenue expectations and the azn stock price.
• Partnerships, licensing deals, and milestone payments — positive deals or milestone recognition may support the azn stock price.

Macro and market drivers

• Currency fluctuations: as AstraZeneca reports in certain currencies, USD/GBP movements can impact reported results and the azn stock price across listings.
• Interest rates and valuation multiples: higher rates often compress biotech/pharma valuation multiples, influencing the azn stock price.
• Market sentiment and sector rotations: flows into or out of healthcare or pharma can move the azn stock price independently of company news.

Analyst ratings and price targets

Analyst coverage plays a role in setting expectations around the azn stock price. Research reports typically include buy/hold/sell recommendations and price targets. Aggregated analyst consensus and revisions to earnings estimates can influence investor perception of an appropriate azn stock price range.

Sources of analyst aggregation include dedicated data services and major financial news providers. When reviewing analyst-driven azn stock price commentary, check the date of the report and whether estimates include or exclude one-time items.

Trading considerations and liquidity

Liquidity and execution are practical concerns when trading AZN:

• Trading volumes: ADR listings often have different average daily volume than home-market ordinary shares. Higher volume improves trade execution and narrows the bid-ask spread, which affects the effective azn stock price paid by traders.
• Bid-ask spreads: Wider spreads increase slippage; use limit orders to control execution price relative to the quoted azn stock price.
• Market vs limit orders: Market orders guarantee execution but not price, especially risky around earnings or major news that can move the azn stock price rapidly.
• Time-of-day effects: Liquidity tends to be deeper during core session hours — pre-market and after-hours trades can be thinner and more volatile for the azn stock price.

How to check the current AZN stock price

You can check the azn stock price through several reliable channels. For ease and broad accessibility, consider the following:

• Exchange pages and consolidated tape: official exchange pages show the azn stock price with specification if the data are realtime or delayed.
• Financial news portals and market-data providers: many present charts, alerts and metric dashboards for the azn stock price.
• Broker platforms: registered broker-dealers supply real-time azn stock price feeds for account holders and advanced charting tools.
• Mobile apps and market terminals: mobile apps deliver push alerts on azn stock price moves, while professional terminals offer depth-of-book data.

If you trade or monitor AZN frequently, the Bitget platform provides market access and tools to view real-time price quotes and place orders. Bitget’s interface is designed for both new and experienced users to view the azn stock price, historical charts, and key metrics in one place.

Risks and investor considerations

The azn stock price can be affected by risks specific to AstraZeneca and the pharmaceutical industry, including:

• Clinical and regulatory risk: negative trial results or regulatory delays can move the azn stock price downward.
• Competitive risk: rivals launching competing drugs or biosimilars can reduce market share and pressure the azn stock price.
• Pricing and reimbursement risk: policy changes affecting drug pricing can alter revenue and the azn stock price.
• Operational and supply-chain risk: manufacturing or distribution issues may affect sales and the azn stock price.

General market risks — economic downturns, liquidity shocks, and sector re-ratings — also influence the azn stock price.

This content is factual and educational only; it is not investment advice.

Recent news and events (summary)

As of 2026-01-28, according to Benzinga, market data snapshots referenced AZN at a quoted price of $89.61 (down 0.37% on that snapshot). The same Benzinga dataset also highlighted related biotech transactions and strategic collaborations involving companies that intersect with AstraZeneca’s research scope.

Notable items from the Benzinga feed include:

• HarbourBioMed exercised warrants tied to Spruce Biosciences and advanced collaborations in the biotech space. As reported by Benzinga, HarbourBioMed expanded its strategic collaborations, which in November 2025 included an update and advancement of its global strategic collaboration with AstraZeneca PLC. These developments illustrate the collaboration landscape that can indirectly affect investor sentiment toward the azn stock price.
• The Benzinga snapshot showed AZN trading at $89.61 at the time of the report, alongside pricing for other industry names. The Benzinga feed (© 2026 Benzinga.com) provides real-time and snapshot market data used by traders and analysts.

As always, company press releases and official filings are primary sources for corporate developments that may move the azn stock price.

Valuation and financials

Recent financial results

Investors use AstraZeneca’s reported revenues, operating income, EPS and guidance to value the company. Quarterly earnings releases and annual reports contain the core numbers that analysts fold into models that derive implied azn stock price targets.

Where to find recent figures:

• Company investor relations releases and earnings presentations show reported revenue, EPS, and guidance ranges that drive short-term azn stock price reactions.
• Financial data platforms summarize key figures and historical trends for revenue and profitability.

Valuation metrics

Common valuation ratios applied to AZN include:

• Price-to-Earnings (P/E): compares the azn stock price to trailing or forward EPS.
• Enterprise Value to EBITDA (EV/EBITDA): useful for cross-company operational comparisons.
• Price-to-Sales (P/S): helpful when earnings are volatile or negative in certain biotech peers.

Interpreting these metrics in context of peers and sector averages helps frame whether the current azn stock price reflects a premium or discount.

Comparisons and peers

AstraZeneca is often benchmarked against large-cap pharmaceutical peers for relative valuation and performance comparisons. Peers include major global pharmaceutical companies, which provide context for how the azn stock price stacks up in terms of growth, margins and yield.

Peer comparisons typically examine revenue growth, R&D intensity, pipeline strength and valuation multiples — all important when assessing the reasonableness of the azn stock price.

ADR / International investor considerations

For investors holding ADR/ADS in the U.S. or ordinary shares in the U.K., several cross-border factors affect exposure to the azn stock price:

• Currency effects: ADRs convert dividends and earnings into USD; GBP/USD movements can influence reported results and ADR pricing.
• Tax withholding: foreign tax rules and withholding on dividends can differ between ADR and ordinary-share holders.
• ADR mechanics: depositary banks manage conversion, distribution and recordkeeping — affecting how corporate actions (dividends, rights) are delivered to ADR holders and thus how the azn stock price reflects those actions.

International investors should confirm tax treatment and ADR terms with custodians and broker platforms.

See also

• AstraZeneca company page (company filings and investor relations)
• Pharmaceutical industry overview and sector performance
• ADR / ADS mechanics and investor guides
• Market data sources and charting tools (exchange data, major financial data providers)

References and data sources

• Exchange pages and consolidated tape for AZN quotes (official exchange feeds)
• Major market-data providers and financial news services for azn stock price snapshots
• Company investor relations disclosures and regulatory filings for financial statements and corporate actions
• Benzinga market snapshot and reporting (referenced above for price snapshot and related biotech collaboration news)

As of 2026-01-28, according to Benzinga, the azn stock price was quoted at $89.61 (Benzinga market data snapshot). This report also described HarbourBioMed’s ongoing collaborations and exercises of warrants affecting related biotech companies, and referenced AstraZeneca’s collaborations announced in late 2025.

External links

• AstraZeneca investor relations (company reports and press releases)
• Exchange pages for AZN (U.S. ADR) and the LSE listing (ordinary shares)
• Market-data portals and brokerage platforms that display the azn stock price and related metrics